Results Of Soc-2082 Phase II Study Using Metronomic Gemcitabine, Doxorubicin, And Docetaxel Plus Nivolumab As Second/Third-Line Therapy For Advanced Leiomyosarcoma
Docetaxel;Doxorubicin;Gemcitabine;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Results Of Soc-2082 Phase II Study Using Metronomic Gemcitabine, Doxorubicin, And Docetaxel Plus Nivolumab As Second/Third-Line Therapy For Advanced Leiomyosarcoma ### Output: Docetaxel;Doxorubicin;Gemcitabine;Nivolumab